Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Antibiotics "may help Salmonella spread"
mouse
Researchers say their findings may have wider implications for human health.
US study finds mice get sicker and shed more bacteria after treatment

Findings from a US study have revealed that treating salmonella-infected mice with antibiotics may make them sicker and more contagious.

Scientists from the Stanford University School of Medicine gave oral antibiotics to mice infected with Salmonella typhimurium.

In the US, S. typhimurium is responsible for around 1 million cases of food poisoning, 19,000 hospitalisations and 400 deaths every year. Around 70 to 90 per cent of those infected shed relatively small numbers of bacteria, meaning they are not very contagious, while 10 to 30 per cent are asymptomatic, but shed huge amounts of bacteria. These are known as the "superspreaders".

A minority of the infected mice (one in five) were asymptomatic, but were shedding large amounts of bacteria in their faeces. According to findings published online in the Proceedings of the National Academy of Sciences, treating these superspreaders with antibiotics made no difference to their condition or the amount of bacteria shed.

The rest of the infected mice, who were showing symptoms, were shedding only light amounts of bacteria. After being treated with the antibiotic Streptomycin, however, these mice became sicker and started shedding bacteria on a similar level to the superspreaders. Another antibiotic, neomycin, produced the same results.

Senior author Denise Monack said: "They lost weight, had ruffled fur and hunched up in the corners of their cages. They also began to shed much larger quantities of bacteria."

Stanford researchers say they are concerned about the public and animal health implications if the same is true in livestock animals.

However, they say their research offers clues for identifying superspreaders, which could help curtail or prevent epidemics. The superspreaders had a smaller immune response than the other mice. Professor Denise Monack says this explains their absence of symptoms.

"Instead of jousting with the germ, they tolerate it. Their immune cells have been rewired and aren't responding to the inflammatory signals in the intestines in the same way."

Being able to identify the superspreaders could help deal with or even prevent epidemics, researchers say, as those who are asymptomatic evade treatment, yet are more contagious. Stanford scientists hope their findings indicate the possibility of a blood test to identify superspreaders.

Professor Monack said the findings may have wider implications for human health: "If we can figure out what leads to this immune dampening in superspreaders, it could potentially be helpful in suppressing symptoms of people with chronic inflammatory intestinal disorders, such as Crohn's disease or inflammatory bowel disease."

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.